SS
DWTX

SBI Securities’s Dogwood Therapeutics DWTX Stock Holding History

SBI Securities’s Portfolio DWTX Stock Details DWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1
Closed -$8 – 4271
2025
Q3 		$8 Sell
1
-152
-99% -$756 ﹤0.01% 4071
2025
Q2 		$730 Sell
153
-35
-19% -$169 ﹤0.01% 2814
2025
Q1 		$942 Buy
188
+180
+2,250% +$1.22K ﹤0.01% 2610
2024
Q4 		$20 Buy
+8
New +$26 ﹤0.01% 3834

Other funds holding DWTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

SBI Securities's DWTX Position: Q4 2025 in Review

SBI Securities sold out of Dogwood Therapeutics (DWTX) in Q4 2025, closing a stake of 1 share — an estimated $8 sold.

SBI Securities first reported a position in DWTX in Q4 2024 and held it in 4 quarters. The position peaked at $942 in Q1 2025. 10 funds tracked by Wall St. Rank hold DWTX as of Q4 2025.

  • SBI Securities reported no remaining Dogwood Therapeutics position as of Q4 2025 after selling out during the quarter.
  • SBI Securities sold 1 Dogwood Therapeutics share in Q4 2025, an estimated $8.
  • SBI Securities first reported a position in Dogwood Therapeutics in Q4 2024 and held it in 4 quarters.
  • SBI Securities's Dogwood Therapeutics position peaked at $942 in Q1 2025.
  • 10 funds tracked by Wall St. Rank held Dogwood Therapeutics as of Q4 2025.

Based on SBI Securities's 13F filing for Q4 2025, filed 3 Feb 2026.